Can-Fite BioPharma Ltd. (TLV:CANF)
Israel · Delayed Price · Currency is ILS · Price in ILA 250.10
-11.30 (-4.32%)
Nov 12, 2026, 5:24 PM IST
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 15.16 million as of November 12, 2026. It is the 44,957th most valuable company in the world and the 475th biggest in Israel. Its market cap has decreased by 70.39% in one year.
Market Cap
15.16M
Enterprise Value
-5.67M
Revenue
1.21M
Global Rank
Country Rank
#475 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from 69.53M to 15.16M, a decrease of -78.19%. That is a compound annual growth rate of -8.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 15.16M | -80.70% |
| Dec 31, 2025 | 78.55M | 38.59% |
| Dec 31, 2024 | 56.68M | 77.98% |
| Dec 31, 2023 | 31.85M | -53.53% |
| Dec 29, 2022 | 68.52M | -42.86% |
| Dec 30, 2021 | 119.91M | 29.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 184.57M |
| Matricelf | 81.05M |
| Clal Biotechnology Industries | 34.51M |
| Purple Biotech | 32.42M |
| BioLineRx | 29.87M |
| BioLight Life Sciences | 26.18M |
| XTL Biopharmaceuticals | 17.22M |
| Evogene | 13.92M |